DRUG Change in Working Capital - Cash Flow Statement - Bright Minds Biosciences Inc. - IntrinsicAlpha

Bright Minds Biosciences Inc. DRUG

Healthcare - Biotechnology - NASDAQ - CA

$ 37.24

9.88 %

$ 262 M

Market Cap

-266.0

P/E

DRUG - CHANGE IN WORKING CAPITAL

Change in Working Capital DRUG - Bright Minds Biosciences Inc.

39.8 K

LAST VALUE

-76.59%

2 YEAR CAGR

1.64%

5 YEAR CAGR

0.00%

10 YEAR CAGR